SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-029537
Filing Date
2021-11-22
Accepted
2021-11-22 15:06:05
Documents
51
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1807972
2 ex31-1.htm EX-31.1 18615
3 ex32-1.htm EX-32.1 8305
  Complete submission text file 0001493152-21-029537.txt   7497188

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT atrx-20210930.xsd EX-101.SCH 44900
5 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT atrx-20210930_cal.xml EX-101.CAL 34670
6 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT atrx-20210930_def.xml EX-101.DEF 235362
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT atrx-20210930_lab.xml EX-101.LAB 369839
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT atrx-20210930_pre.xml EX-101.PRE 292403
9 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1325592
Mailing Address P.O. BOX 2161 WAKE FOREST NC 27588
Business Address P.O. BOX 2161 WAKE FOREST NC 27588 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13789 | Film No.: 211431986
SIC: 2834 Pharmaceutical Preparations